Literature DB >> 24064871

Splenectomy in patients with traumatic brain injury: protective or harmful? A National Trauma Data Bank analysis.

Pedro G Teixeira1, Efstathios Karamanos, Obi T Okoye, Peep Talving, Kenji Inaba, Lydia Lam, Demetrios Demetriades.   

Abstract

BACKGROUND: Experimental data have demonstrated a potential survival benefit for animals undergoing splenectomy immediately after traumatic brain injury. The aim of this study was to investigate the effect of splenectomy on survival in patients with moderate or severe traumatic brain injury (TBI).
METHODS: This is a National Trauma Data Bank (2002-2009) analysis and included patients sustaining moderate or severe blunt head trauma (head Abbreviated Injury Scale [AIS] score, 3-5), with an associated splenic injury and an exploratory laparotomy. The population was divided into two arms: those that had a splenectomy and those who did not. The primary outcome was in-hospital mortality. Logistic regression was performed to adjust for factors that were significantly different between the study groups.
RESULTS: During the 9-year study period, 2,625 patients met the criteria for inclusion in the analysis. Of these, 1,450 (55%) had a splenectomy, and 1,175 (45%) did not. Mortality was 13% for the splenectomized compared with 9% for the nonsplenectomized population (p = 0.001). After logistic regression, mortality remained significantly higher in the splenectomized population (adjusted odds ratio [AOR], 1.62; 95% confidence interval [CI], 1.16-2.26; p = 0.005). After stratification according to the severity of brain injury, the association between splenectomy and increased mortality persisted for both patients with moderate head injury (8% vs. 6%; AOR, 2.43; 95% CI, 1.26-4.71; p = 0.008) and for patients with severe head injury (17% vs. 10%; AOR, 1.49; 95% CI, 1.03-2.19; p = 0.036).
CONCLUSION: Splenectomy was independently associated with increased mortality in patients with moderate or severe TBI. This finding warrants further investigation regarding splenic preservation in patients with TBI. LEVEL OF EVIDENCE: Therapeutic study, level IV.

Entities:  

Mesh:

Year:  2013        PMID: 24064871     DOI: 10.1097/TA.0b013e31829bb976

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  5 in total

Review 1.  Nonoperative management of blunt splenic injury: what is new?

Authors:  G A Watson; M K Hoffman; A B Peitzman
Journal:  Eur J Trauma Emerg Surg       Date:  2015-04-15       Impact factor: 3.693

2.  Reassessing mechanism as a predictor of pediatric injury mortality.

Authors:  Haley E Beck; Sushil Mittal; David Madigan; Randall S Burd
Journal:  J Surg Res       Date:  2015-06-24       Impact factor: 2.192

3.  Nonoperative Management of Blunt Splenic Trauma in Patients with Traumatic Brain Injury: Feasibility and Outcomes.

Authors:  Navpreet K Dhillon; Galinos Barmparas; Gretchen M Thomsen; Kavita A Patel; Nikhil T Linaval; Emma Gillette; Daniel R Margulies; Eric J Ley
Journal:  World J Surg       Date:  2018-08       Impact factor: 3.352

4.  Post-TBI splenectomy may exacerbate coagulopathy and platelet activation in a murine model.

Authors:  Mackenzie C Morris; Devin John; Kathleen E Singer; Ryan Moran; Emily McGlone; Rosalie Veile; Holly S Goetzman; Amy T Makley; Charles C Caldwell; Michael D Goodman
Journal:  Thromb Res       Date:  2020-08-07       Impact factor: 3.944

Review 5.  Overview of Traumatic Brain Injury: An Immunological Context.

Authors:  Damir Nizamutdinov; Lee A Shapiro
Journal:  Brain Sci       Date:  2017-01-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.